Tag: Trastuzumab deruxtecan

Tag Visualization: Top 50 related tags by occurrence

United States: 3 articlesUnited...Health: 4 articlesHealthThomson Reuters: 2 articlesThoms...Medicine: 19 articlesMedicineClinical medicine: 30 articlesClinical medicineChina: 3 articlesChinaHealth care: 14 articlesHealth careGetty Images: 2 articlesGetty...Medical research: 4 articlesMedical...Trastuzumab: 38 articlesTrastuzumabImmunology: 38 articlesImmunologyCancer treatments: 32 articlesCancer treatmentsBreast cancer: 32 articlesBreast cancerSpecialty drugs: 4 articlesSpecial...AstraZeneca: 45 articlesAstraZenecaCancer immunotherapy: 3 articlesCancer...Antineoplastic drugs: 39 articlesAntineoplastic drugsPembrolizumab: 3 articlesPembro...Drugs: 9 articlesDrugsOrphan drugs: 36 articlesOrphan drugsLung cancer: 5 articlesLung can...Tucatinib: 2 articlesTucat...Life Sciences: 10 articlesLife Scienc...Breakthrough therapy: 33 articlesBreakthrough therapyAstraZeneca plc: 12 articlesAstraZeneca ...Health sciences: 12 articlesHealth scien...Targeted therapy: 2 articlesTarge...Metastatic breast cancer: 4 articlesMetasta...Daiichi Sankyo: 42 articlesDaiichi SankyoMorpholines: 2 articlesMorph...Brain metastasis: 4 articlesBrain m...Clinical endpoint: 3 articlesClinic...Durvalumab: 6 articlesDurvaluma...u.s. food and drug administration: 2 articlesu.s. ...Antibody-drug conjugates: 50 articlesAntibody-drug conjugatesTrastuzumab emtansine: 17 articlesTrastuzumab emt...Trastuzumab deruxtecan: 64 articlesTrastuzumab deruxtecanHER2/neu: 31 articlesHER2/neuAntibody-drug conjugate: 20 articlesAntibody-drug co...Pertuzumab: 8 articlesPertuzumabNon-small-cell lung carcinoma: 4 articlesNon-sma...Progression-free survival: 2 articlesProgr...Small-cell carcinoma: 4 articlesSmall-c...Oxford–AstraZeneca COVID-19 vaccine: 4 articlesOxford–...Sankyo Co.: 2 articlesSanky...Daiichi Sankyo Co Ltd: 7 articlesDaiichi S...Non-small-cell lung cancer: 4 articlesNon-sma...HER2: 20 articlesHER2Nancy Lin: 3 articlesNancy ...Deruxtecan: 2 articlesDerux...

Recent Related Articles to Trastuzumab deruxtecan

AstraZeneca's Enhertu included in China's state insurance reimbursement - TradingView

Added to Collection on: 2024-11-28 20:39:31

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
AstraZeneca cancer drug Enhertu added for reimbursement in China despite probe

Added to Collection on: 2024-11-28 17:59:34

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
AstraZeneca (AZN) Sees Its Cancer Drug Added to China's Reimbursement List - TipRanks

Added to Collection on: 2024-11-28 17:39:21

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
AstraZeneca's Enhertu cancer drug added to China health insurance scheme - The Times

Added to Collection on: 2024-11-28 21:47:02

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Datopotamab Deruxtecan Application in the EU for Patients with Advanced Nonsquamous ...

Added to Collection on: 2024-12-24 14:49:14

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
AZ, Daiichi get FDA nod for Dato-DXd in breast cancer | pharmaphorum

Added to Collection on: 2025-01-19 02:36:53

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Boost to Enhertu's prospects as FDA clears Roche diagnostic - pharmaphorum

Added to Collection on: 2025-02-02 21:10:02

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
AstraZeneca, Daiichi Sankyo's Enhertu recommended for approval in EU - TipRanks.com

Added to Collection on: 2025-02-28 15:56:32

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
AstraZeneca breast cancer therapy wins recommendation for EU approval - Morningstar

Added to Collection on: 2025-02-28 15:37:57

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
AstraZeneca, Daiichi Sankyo's Enhertu recommended for approval in EU | Markets Insider

Added to Collection on: 2025-02-28 14:37:34

Tags for this article:

Click the tags to see associated articles and topics

View Article Details